journal article·2017-07-04Open access

SiRNA-mediated silencing of Snail-1 induces apoptosis and alters micro RNA expression in human urinary bladder cancer cell line

Seyed Mohammad Hossein Musavi Shenas, Behzad Mansoori, Ali Mohammadi, Shima Salehi, Behzad Kaffash, Behnaz Talebi, Zohreh Babaloo, Dariush Shanehbandi, Behzad Baradaran

Abstract

Snail-1 known as one of the important transcription factor is a mediator of survival and cell migration, and expression is raised in numerous cancer types. Snail-1 gene may show a role in recurrence of several cancers including bladder cancer by down-regulating E-cadherin, inducing an epithelial to mesenchymal transition (EMT) and its related microRNAs (miRNAs). The aim of this study was to investigate the effect of a specific Snail-1 siRNA on apoptosis and alter EMT related miRNAs of EJ-138 (bladder cancer) cells. The cells were transfected with siRNAs using transfection reagent. The cytotoxic effects of Snail-1 siRNA, on bladder cancer cells were determined using MTT assay. Relative Snail-1 mRNA levels were measured by QRT- PCR, respectively. Apoptosis was measured by TUNEL test based on labeling of DNA strand breaks. We also evaluated miR-29b, miR-21, and miR-203 expression by QRT-PCR to determine alteration in miRNAs expression involved in EMT. Snail-1 siRNA significantly reduced mRNA expression levels in 48 h after transfection at the concentration of 60 pmol in bladder cancer cells. We also showed that the silencing of Snail-1 led to the induction of apoptosis. miR-21 and miR-29b depression have been shown in Snail-1 suppressed group in EJ-138 cells in vitro. These results propose that Snail-1 might play an important role in the progression of bladder cancer, and be a potential therapeutic target for trigger apoptosis and suppression of EMT-related miRNAs in bladder cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer Cells and Metastasis · Fibroblast Growth Factor Research · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;

International Branch (Aras), Tabriz University of Medical Sciences, Tabriz, Iran;

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran;

Department of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran

References (26)

Show source-provided references
1. 10.1038/onc.2009.21410.1038/onc.2009.214 ↗
2. 10.1158/1535-7163.MCT-06-052110.1158/1535-7163.MCT-06-0521 ↗
3. 10.1016/S0025-7753(08)76435-210.1016/S0025-7753(08)76435-2 ↗
4. 10.1002/cncr.2094610.1002/cncr.20946 ↗
5. 10.3322/caac.2000610.3322/caac.20006 ↗
6. 10.1016/j.yexcr.2007.04.00110.1016/j.yexcr.2007.04.001 ↗
7. 10.1016/j.biopha.2015.08.03210.1016/j.biopha.2015.08.032 ↗
8. 10.1016/j.cellsig.2014.09.01810.1016/j.cellsig.2014.09.018 ↗
9. 10.1038/onc.2012.26010.1038/onc.2012.260 ↗
10. 10.1007/978-1-4614-5647-6_110.1007/978-1-4614-5647-6_1 ↗
11. 10.15171/apb.2016.02410.15171/apb.2016.024 ↗
12. Mansoori B · Cell Mol Biol (Noisy-le-Grand) · 2014 · 61 · 1
13. Mansoori B · Adv Pharm Bull · 2014 · 4 · 313
14. Montazami N · Cell Mol Biol (Noisy-le-Grand) · 2015 · 61 · 98
15. 10.1038/sj.onc.120999710.1038/sj.onc.1209997 ↗
16. 10.1158/0008-5472.CAN-07-231810.1158/0008-5472.CAN-07-2318 ↗
17. Sahranavard S · Res Pharm Sci · 2010 · 4 · 133
18. 10.1007/s12013-012-9451-110.1007/s12013-012-9451-1 ↗
19. 10.1016/j.cancergencyto.2007.05.00510.1016/j.cancergencyto.2007.05.005 ↗
20. Sugimachi K · . Clin Cancer Res · 2003 · 9 · 2657
21. 10.1093/jmcb/mjs04810.1093/jmcb/mjs048 ↗
22. 10.7150/ijms.382710.7150/ijms.3827 ↗
23. 10.1038/ncb190510.1038/ncb1905 ↗
24. 10.1200/JCO.2008.21.213410.1200/JCO.2008.21.2134 ↗
25. 10.1038/emboj.2011.31210.1038/emboj.2011.312 ↗
26. Zhang A · Anticancer Res · 2008 · 28 · 621